Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance

Eleonora Petito; Giuseppe Guglielmini; Edoardo De Robertis; Cecilia Becattini; Laura Franco; Emanuela Falcinelli; Chiara Conti; Fabio Gori; Gaetano Vaudo; Vittorio Cerotto; Ugo Paliani; Letizia Mezzasoma; Barbara Camilloni; Paolo Gresele; COVIR study investigators

doi:10.1055/a-2562-4516

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2025; 125(07): 660-672
DOI: 10.1055/a-2562-4516

Cellular Hemostasis and Platelets

Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance

Eleonora Petito

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Giuseppe Guglielmini

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Edoardo De Robertis

²Division of Anaesthesia, Analgesia, and Intensive Care, Department of Medicine and Surgery, University of Perugia, Perugia, Italy

,

Cecilia Becattini

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Laura Franco

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Emanuela Falcinelli

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Chiara Conti

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

Fabio Gori

³Section of Anesthesia, Intensive Care, and Pain Medicine, Azienda Ospedaliera-Universitaria Santa Maria della Misericordia, Perugia, Italy

,

Gaetano Vaudo

⁴Unit of Internal Medicine, Terni University Hospital, Terni, Italy

,

Vittorio Cerotto

⁵Section of Anesthesia, Intensive Care and Pain Medicine, Department of Emergency and Urgency, Città di Castello Hospital, Città di Castello, Italy

,

Ugo Paliani

⁶Division of Internal Medicine, ASL 1 Umbria, Città di Castello, Italy

,

Letizia Mezzasoma

⁷Department of Medicine and Surgery, Section of Biosciences and Medical Embryology, University of Perugia, Perugia, Italy

,

Barbara Camilloni

⁸Department of Medicine and Surgery, Microbiology and Clinical Microbiology, University of Perugia, Perugia, Italy

,

Paolo Gresele

¹Division of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy

,

COVIR study investigators

› Author Affiliations

Abstract

Background

Oxidative stress has been associated with COVID-19-related thrombotic complications. No investigations have explored nitric oxide (NO) and radical oxygen species (ROS) production by platelets. Indeed, activated platelets generate both NO and ROS which in turn regulate platelet function. The aim of the present study was to measure platelet NO and ROS production in COVID-19 patients, to assess whether they correlate with disease outcome and to clarify the mechanisms of platelet NO/ROS imbalance in COVID-19.

Material and Methods

Hospitalized mild and severe COVID-19 patients, age- and sex-matched healthy controls, and patients hospitalized in intensive care units for reasons different from COVID-19 were enrolled. Platelet NO and ROS production was assessed by flow cytometry. The oxidant and antioxidant capacity of COVID-19 plasma was assessed using lipid peroxidation and ORAC assays. The effect of COVID-19 plasma on platelet NO production and the impact of antioxidants on it were studied by flow cytometry.

Results

Platelets from COVID-19 patients displayed an altered NO/ROS balance, with defective NO and increased ROS production. Platelet NO production was significantly lower in patients who developed thrombotic events during hospitalization. COVID-19 patients showed significantly increased plasma lipid peroxidation and reduced antioxidant capacity compared with healthy controls. Concordantly, plasma from COVID-19 patients impaired NO production by healthy control species platelets, which was restored by the antioxidant agent Hydroxy-TEMPO.

Conclusion

Our findings suggest that the unbalanced platelet NO/ROS production in COVID-19 plays a role in the thrombotic complications of SARS-CoV-2 infection. The restoration of platelet NO production may represent a therapeutic target for the prevention of thrombotic events in COVID-19 patients.

Keywords

COVID-19 - nitric oxide - platelets - reactive oxygen species - thrombosis

Full Text

References

References
1 Gorog DA, Storey RF, Gurbel PA. et al. Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 2022; 19 (07) 475-495
2 Alam MS, Czajkowsky DM. SARS-CoV-2 infection and oxidative stress: pathophysiological insight into thrombosis and therapeutic opportunities. Cytokine Growth Factor Rev 2022; 63: 44-57
3 Montiel V, Lobysheva I, Gérard L. et al. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine 2022; 77: 103893
4 Alhayaza R, Haque E, Karbasiafshar C, Sellke FW, Abid MR. The relationship between reactive oxygen species and endothelial cell metabolism. Front Chem 2020; 8: 592688
5 Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 2000; 86 (03) 347-354
6 Hsieh H-J, Liu C-A, Huang B, Tseng AH, Wang DL. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications. J Biomed Sci 2014; 21 (01) 3
7 Martínez MC, Andriantsitohaina R. Reactive nitrogen species: molecular mechanisms and potential significance in health and disease. Antioxid Redox Signal 2009; 11 (03) 669-702
8 Gresele P, Momi S, Guglielmini G. Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. Biochem Pharmacol 2019; 166: 300-312
9 Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012; 33 (07) 829-837 , 837a–837d
10 Atanasovska E, Petrusevska M, Zendelovska D. et al. Vitamin D levels and oxidative stress markers in patients hospitalized with COVID-19. Redox Rep 2021; 26 (01) 184-189
11 Martín-Fernández M, Aller R, Heredia-Rodríguez M. et al. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol 2021; 48: 102181
12 Mehri F, Rahbar AH, Ghane ET, Souri B, Esfahani M. Changes in oxidative markers in COVID-19 patients. Arch Med Res 2021; 52 (08) 843-849
13 Abouhashem AS, Singh K, Azzazy HME, Sen CK. Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19?. Antioxid Redox Signal 2020; 33 (02) 59-65
14 Abbas M, Verma S, Verma S. et al. Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome. J Med Virol 2021; 93 (09) 5446-5451
15 Violi F, Oliva A, Cangemi R. et al. Nox2 activation in Covid-19. Redox Biol 2020; 36: 101655
16 Badawy MA, Yasseen BA, El-Messiery RM. et al. Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality. eLife 2021; 10: e69417
17 Laforge M, Elbim C, Frère C. et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol 2020; 20 (09) 515-516
18 Dominic P, Ahmad J, Bhandari R. et al. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol 2021; 43: 101982
19 Wang J, Mei F, Bai L. et al. Serum nitrite and nitrate: a potential biomarker for post-COVID-19 complications?. Free Radic Biol Med 2021; 175: 216-225
20 Alvarez RA, Berra L, Gladwin MT. Home nitric oxide therapy for COVID-19. Am J Respir Crit Care Med 2020; 202 (01) 16-20
21 Redaelli S, Magliocca A, Malhotra R. et al. Nitric oxide: clinical applications in critically ill patients. Nitric Oxide 2022; 121: 20-33
22 Hedenstierna G, Chen L, Hedenstierna M, Lieberman R, Fine DH. Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19. Nitric Oxide 2020; 103: 1-3
23 Fang W, Jiang J, Su L. et al. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med 2021; 163: 153-162
24 Akaberi D, Krambrich J, Ling J. et al. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol 2020; 37: 101734
25 Middleton EA, He X-Y, Denorme F. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 2020; 136 (10) 1169-1179
26 Manne BK, Denorme F, Middleton EA. et al. Platelet gene expression and function in patients with COVID-19. Blood 2020; 136 (11) 1317-1329
27 Denorme F, Manne BK, Portier I. et al. COVID-19 patients exhibit reduced procoagulant platelet responses. J Thromb Haemost 2020; 18 (11) 3067-3073
28 Petito E, Falcinelli E, Paliani U. et al; COVIR study investigators. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis 2021; 223 (06) 933-944
29 Zuo Y, Zuo M, Yalavarthi S. et al. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis 2021; 51 (02) 446-453
30 Léopold V, Chouchane O, Butler JM. et al Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress, and energy metabolism failure compatible with cell death. Res Pract Thromb Haemost 2023; 7 (07) 102213
31 Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008; 28 (03) s11-s16
32 Di Pasquale A, Radomski N, Mangone I, Calistri P, Lorusso A, Cammà C. SARS-CoV-2 surveillance in Italy through phylogenomic inferences based on Hamming distances derived from pan-SNPs, -MNPs and -InDels. BMC Genomics 2021; 22 (01) 782
33 Petito E, Colonna E, Falcinelli E. et al. Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers. Br J Haematol 2022; 198 (02) 257-266
34 Petito E, Amison RT, Piselli E. et al. A dichotomy in platelet activation: evidence of different functional platelet responses to inflammatory versus haemostatic stimuli. Thromb Res 2018; 172: 110-118
35 Gresele P, Migliacci R, Vedovati MC. et al. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Thromb Res 2009; 123 (03) 444-451
36 Gresele P, Catalano M, Giammarresi C. et al. Platelet activation markers in patients with peripheral arterial disease—a prospective comparison of different platelet function tests. Thromb Haemost 1997; 78 (06) 1434-1437
37 Messina F, Guglielmini G, Curini M, Orsini S, Gresele P, Marcotullio MC. Effect of substituted stilbenes on platelet function. Fitoterapia 2015; 105: 228-233
38 Gresele P, Pignatelli P, Guglielmini G. et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 2008; 138 (09) 1602-1608
39 Purgatorio G, Piselli E, Guglielmini G. et al. Germline GATA2 variant disrupting endothelial eNOS function and angiogenesis can be restored by c-Jun/AP-1 upregulation. Haematologica 2022; 107 (05) 1072-1085
40 Momi S, Caracchini R, Falcinelli E, Evangelista S, Gresele P. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Arterioscler Thromb Vasc Biol 2014; 34 (04) 820-829
41 He G, Zhang Y, Feng Y. et al. SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation. J Cell Mol Med 2024; 28 (07) e18212
42 Mencacci A, Gili A, Camilloni B. et al. Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection. J Infect Public Health 2022; 15 (09) 983-985
43 Hottz ED, Azevedo-Quintanilha IG, Palhinha L. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 2020; 136 (11) 1330-1341
44 Li X-K, Lu Q-B, Chen W-W. et al. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med 2018; 10 (459) eaat4162
45 Camargo RL, Bombassaro B, Monfort-Pires M. et al. Plasma angiotensin II is increased in critical coronavirus disease 2019. Front Cardiovasc Med 2022; 9: 847809
46 Veenith T, Martin H, Le Breuilly M. et al. High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep 2022; 12 (01) 10484
47 Varga Z, Flammer AJ, Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395 (10234): 1417-1418
48 Gama WM, Oliveira LB, Chaves YO. et al. Increased levels of reactive oxygen species in platelets and platelet-derived microparticles and the risk of respiratory failure in HIV/AIDS patients. Mem Inst Oswaldo Cruz 2020; 115: e200082
49 Hottz ED, Oliveira MF, Nunes PCG. et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost 2013; 11 (05) 951-962
50 Falcinelli E, Petito E, Gresele P. The role of platelets, neutrophils and endothelium in COVID-19 infection. Expert Rev Hematol 2022; 15 (08) 727-745
51 Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 2007; 101 (07) 654-662
52 Cozzi MR, Guglielmini G, Battiston M. et al. Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. Blood 2015; 125 (04) 697-705
53 Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88 (08) 756-762
54 Radziwon-Balicka A, Lesyk G, Back V. et al. Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation. Cardiovasc Res 2017; 113 (14) 1719-1731
55 McCreary MR, Schnell PM, Rhoda DA. Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19). Sci Rep 2022; 12 (01) 10978
56 Lundberg JO, Weitzberg E. Nitric oxide signaling in health and disease. Cell 2022; 185 (16) 2853-2878
57 Abais JM, Xia M, Zhang Y, Boini KM, Li PL. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?. Antioxid Redox Signal 2015; 22 (13) 1111-1129
58 Hernandez-Cuellar E, Tsuchiya K, Hara H. et al. Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol 2012; 189 (11) 5113-5117
59 Bai B, Yang Y, Wang Q. et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis 2020; 11 (09) 776
60 Rodrigues TS, de Sá KSG, Ishimoto AY. et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med 2021; 218 (03) e20201707
61 Vogel S, Kamimura S, Smith ML. et al. NLRP3 inflammasome-mediated platelet activation and thrombus formation in sickle cell mice can be targeted by the BTK inhibitor ibrutinib. Blood 2023; 142: 3935
62 Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10 (03) 241-247

Supplementary Material

Supplementary Material